Argyris Tzouvelekis (New Haven, United States of America), Eliza Tsitoura (Heraklion, Crete, Greece)
Role of MUC1 in idiopathic pulmonary fibrosis
Beatriz Ballester (Valencia, Spain), Beatriz Ballester, Javier Milara, Celia Sanz, Sonia González, Ricardo Guijarro, Cecilia Martínez, Julio Cortijo
|  |
New IL-1 family IL-38 is highly expressed in alveolar cells of drug-induced lung injury and idiopathic pulmonary fibrosis
Masaki Tominaga (Kurume, Japan), Masaki Tominaga, Masaki Okamoto, Takashi Kinoshita, Yuki Sakazaki, Masanobu Matsuoka, Shinjiro Kaieda, Tomoaki Hoshino
| |
Nintedanib reduces fibrotic markers in the lung in a model of rheumatoid arthritis associated interstitial lung disease
Lutz Wollin (Biberach Riss, Germany), Elizabeth Redente, Martin Aguilar, Luc Lalire, Benjamin Edelman, Lutz Wollin, David Riches
| |
Cultivating bronchial epithelial cells collected through bronchoscopic microsampling in patients with interstitial lung disease
Nicolas Kahn (Heidelberg, Germany), Nicolas Kahn, Michael Meister, Ralf Eberhardt, Thomas Muley, Marc Schneider, Felix J.F. Herth, Michael Kreuter
| |
Combining immunostaining with micro-computed tomography to visualise the 3D distribution of mast cells in idiopathic pulmonary fibrosis
Ahmad Elmansouri (Havant, United Kingdom), Ahmad Elmansouri, James Cairns, Philipp Schneider, Ian Sinclair, Luca Richeldi, Peter Lackie, Mark G. Jones, Jane A. Warner
|  |
IGFBP-2 a new interesting target in IPF
Julien Guiot (Liège, Belgium), Julien Guiot, Monique Henket, Benjamin Bondue, Jean-Louis Corhay, Renaud Louis
| |
Nintedanib and pirfenidone inhibit collagen synthesis and maturation at several regulatory levels
Larissa Knüppel (Munich, Germany), Larissa Knüppel, Yoshihiro Ishikawa, Michaela Aichler, Katharina Heinzelmann, Rudolf Hatz, Jürgen Behr, Axel Walch, Hans Peter Bächinger, Oliver Eickelberg, Claudia A. Staab-Weijnitz
| |
17(R)-resolvinD1 improves MMP-9/TIMP-1 imbalance leading to amelioration of pulmonary fibrosis in mice
Masakiyo Yatomi (Maebashi, Japan), Masakiyo Yatomi, Takeshi Hisada, Yoshimasa Hachisu, Yasuyuki Saito, Hiroaki Tsurumaki, Yosuke Kamide, Haruka Aoki-Saito, Yasuhiko Koga, Akihiro Ono, Kunio Dobashi, Tamotsu Ishizuka, Masanobu Yamada, Fumikazu Okajima
| |
Mesenchymal stem cells and conditioned medium in myofibroblast modulation and collagen production in vascular adventitia and parenchyma of experimental pulmonary fibrosis model
Renato Goncalves Felix (Botucatu, Brazil), Renato Goncalves Felix, Ana Livia Carvalho Bovolato, Patricia Santos Leão, Amanda Luisa dos Santos, Ana Paula Pereira Velosa, Walcy Rosolia Teodoro, Elenice Deffune, Alexandre Todorovic Fabro, Vera Luiza Capelozzi
| |
Confocal laser endomicroscopy: Identification and quantification of the alveolar compartment
Lizzy Wijmans (Amsterdam, Netherlands), Lizzy Wijmans, Daniel M. de Bruin, Peter I. Bonta, Rene E. Jonkers, Joris J.T.H. Roelofs, Inge A.H. van den Berk, Jouke T. Annema
| |
Natural killer and natural killer T-like cells in bronchoalveolar lavage fluid and peripheral blood in diffuse lung diseases
Eva Padrão (Braga, Portugal), Eva Padrão, Oksana Sokhatska, Marília Beltrão, Carmo Palmares, Patrícia Caetano Mota, Natália Melo, António Morais, Luís Delgado
| |
Club cell secretory protein-CC16 is increased in idiopathic pulmonary fibrosis
Ivette Buendia Roldán (Mexico D.F., Mexico), Ivette Buendia Roldán, Patricia Sierra, Eduardo Montes, Victor Ruiz, Mario H. Vargas-Becerra, Mayra Mejia, Annie Pardo, Moises Selman
| |
B-cell infiltration varies among patients with interstitial lung diseases
Luis Arvelo Castro (Madrid, Spain), Luis Arvelo Castro, Virginia Van Keulen, Mohamed Ali, Marie Christine Aubry, Tobias Peikert, Eva M Carmona
| |
Alveolar lymphocytes (AL) in healthy individuals are mostly effector T cells. The flow cytometry (FC) lesson for interstitial lung diseases (ILD) evaluation
Piotr Kopinski (Bydgoszcz, Poland), Piotr Kopinski, Ewa Wypasek, Andrzej Dyczek, Joanna Golinska, Tomasz Wandtke, Adam Szpechcinski, Joanna Chorostowska-Wynimko
| |
Studies on apoptosis of alveolar lymphocytes (AL) in exogenous allergic alveolitis (EAA)
Piotr Kopinski (Bydgoszcz, Poland), Piotr Kopinski, Grzegorz Przybylski, Andrzej Dyczek, Ewelina Wedrowska, Joanna Golinska, Adam Szpechcinsk1, Joanna Chorostowska-Wynimko
| |
Usefulness of anti-Ro52 antibodies in the BAL of the patients with ILDs. Pilot study
Karina Portillo Carroz (Barcelona, Spain), Karina Portillo Carroz, Iñaki Salvador-Corres, Eva Martinez -Cáceres, Carmen Centeno-Clemente, Aina Teniente-Serra, Juan Ruiz -Manzano, Alejandro Olivé-Marques
| |
Does Rosemary leaves extract can attenuate lung injury in experimental pulmonary fibrosis in rats?
Saloua Ben Khamsa (Ariana, Tunisia), Sana Bahri, Ridha Ben Ali, Khaoula Gasmi, Mona Mlika, Saloua Fazaa, Riadh Ksouri, Raja Serairi, Saloua Ben Khamsa
| |
Tumor necrosis factor-alpha and CD4/CD8 ratio in patients with hypersensitivity pneumonitis
Alaa Rashad Mahmoud (Qena, Egypt), Alaa Rashad Mahmoud, Asmaa Nafady
| |